| Literature DB >> 34026431 |
Eve McGlynn1, Vahid Nabaei1, Elisa Ren2, Gabriel Galeote-Checa1, Rupam Das1, Giulia Curia2, Hadi Heidari1.
Abstract
Neurological diseases are a prevalent cause of global mortality and are of growing concern when considering an ageing global population. Traditional treatments are accompanied by serious side effects including repeated treatment sessions, invasive surgeries, or infections. For example, in the case of deep brain stimulation, large, stiff, and battery powered neural probes recruit thousands of neurons with each pulse, and can invoke a vigorous immune response. This paper presents challenges in engineering and neuroscience in developing miniaturized and biointegrated alternatives, in the form of microelectrode probes. Progress in design and topology of neural implants has shifted the goal post toward highly specific recording and stimulation, targeting small groups of neurons and reducing the foreign body response with biomimetic design principles. Implantable device design recommendations, fabrication techniques, and clinical evaluation of the impact flexible, integrated probes will have on the treatment of neurological disorders are provided in this report. The choice of biocompatible material dictates fabrication techniques as novel methods reduce the complexity of manufacture. Wireless power, the final hurdle to truly implantable neural interfaces, is discussed. These aspects are the driving force behind continued research: significant breakthroughs in any one of these areas will revolutionize the treatment of neurological disorders.Entities:
Keywords: biocompatible encapsulation; brain implantable device; neural interface; neural probe design; wireless data transfer; wireless power
Mesh:
Year: 2021 PMID: 34026431 PMCID: PMC8132070 DOI: 10.1002/advs.202002693
Source DB: PubMed Journal: Adv Sci (Weinh) ISSN: 2198-3844 Impact factor: 16.806
Figure 1Pentagon of design constraints of brain implants. Accessibility to implantation site, density mismatch, apparent recording site impedance, force and tissue insertion dimpling, and the brain tissue viscoelasticity are the main issues to overcome during the design of brain implantable device in chronic implantation.[ ]
Figure 2Significant publications in the field of neural stimulation, which illustrate the place of electrically stimulating probes amongst the development of alternative techniques. The upper section includes such important designs as: the Michigan probe,[ ] the Utah Array,[ ] Polymeric probes,[ ] Mesh Electronics,[ ] and Neuropixels.[ ] The lower half of the timeline includes Electroconvulsive Therapy,[ ] Deep Brain Stimulation,[ ] Transcranial Magnetic Stimulation,[ ] Optogenetics,[ ] Vagus nerve stimulation (VNS),[ ] FEAST,[ ] and μMS.[ ]
Figure 3Summary of the four main brain stimulation techniques based on electrical systems. A) Electroconvulsive Therapy is the most conventional technique, which was replaced by B) Transcranial Magnetic Stimulation for some specific cases of neurological disorders. C) Micromagnetic stimulation requires the implantation of a miniaturized magnetic coil which will not be hindered by immune cell encapsulation. D) Deep Brain Stimulation systems are the most used like commercial products, e.g., Neuropace, Medtronic VNS, and so on. E) Optogenetic stimulation has appeared as an innovative and interesting opportunity during the last decade with the use of Chr2.
Figure 4A) Immune response in the wake of rigid probe implantation. Astrocytes and Microglia adhere to the probe surface, as the foreign body response seeks to encapsulate the implant to protect tissues from further harm. Dystrophic neurons, which have been separated from neuron clusters and suffer degradation, will amass around the probe. B) Reduced foreign body response elicited by a flexible polymer probe. C) The plasma membrane on the outside of a cell is attached to *extracellular matrix (ECM) which is comprised of the proteoglycan complex and collagen fibers.
Summary of most common molecules on the surface of a biomedical implant, and the consequences of the presence of these groups
| Group | Hydrophobicity | Charge | Action in the body | Reference |
|---|---|---|---|---|
| —CH3 (methyl) | Hydrophobic | Neutral | Inflammatory response, increased scar thickness |
[
|
| —NH2 (amino) | Hydrophilic | Positive | Inflammation, cell infiltration, fibrotic reactions |
[
|
| —OH (hydroxyl) | Hydrophilic | Neutral | Inflammation, cell infiltration, fibrotic reactions |
[
|
| —COOH (carboxyl) | Hydrophilic | Negative | Glial scarring and cell infiltration |
[
|
Experimental and design characteristics of recording, stimulating, and bidirectional neural probe systems. The disparity in electrode size is of particular importance, with several examples of bidirectional probes with multiple different electrode diameters on the same shaft. CIC refers to charge injection capacity, while CSC is charge storage capacity
| Probe type | Experiment type | Target | Experiment length | Overall implant size | Electrode size | Impedance | Materials | CIC | CSC | Histology | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stimulating | In vivo | Rodent dorsal hippocampus, 100 µm radius of activation | 4 h of stimulation | 16 microelectrode shafts × 33 µm diameter | N/A | N/A | Tungsten, polyimide insulation, platinum black electrodes | N/A | N/A | c‐fos, DAPI, NeuN |
[
|
| Stimulating | In vivo | Primary auditory cortex (A1) | 1 week | Single shank, 16 site, 100 mm pitch NeuroNexus | N/A | 200–1400 kΩ at 1 kHz | Silicon | N/A | N/A | Iba1 |
[
|
| Bidirectional | In vitro | N/A | N/A | N/A | 10–100 µm diameter | 3.3–3.8 at 1 kHz | Polyimide, titanium, gold, iridium, or platinum electrodes | N/A | 14–21.8 mC cm−2 | Only basic cytotoxicity screening |
[
|
| Bidirectional | In vitro, in vivo | Medial septum, and along the septotemporal axis of the hippocampus | 35 days | 125 µm diameter, PTFE‐coated, PTT0502, World Precision Instruments | 125 µm diameter electrode | 66.71 ± 0.44 kΩ | Nanostructured platinum, polyimide | 3.0 ± 0.1 mC cm−2 | 51.3 ± 0.2 nC | GFAP, with no comparison to uncoated wire |
[
|
| Bidirectional | In vitro, in vivo | Action potentials in the rat cortex | 38 days | 5 mm long, 130 µm wide at maximum, 30 µm thick | 160– 4000 µm2 | 10 kΩ minimum at 1 kHz | Polyimide, PEDOT:PSS, silicon stiffener, gold microelectrodes | 2 mC cm−2 in vivo, 1 mC cm−2 in vitro | N/A | N/A |
[
|
| Recording | Agar Phantom | N/A | N/A | 1.3 mm long Si tip, 6 mm PI cable | 15 or 25 µm diameter | 1.44 MΩ at 1 kHz immersed in Ringer's solution | Polyimide, silicon, iridium oxide or platinum electrodes, gold wiring | N/A | N/A | N/A |
[
|
| Recording | In vivo | Neocortex | 3 h | 8 mm long, 100 µm wide, 50 µm thick | 20 × 20 µm | 50 kΩ | Silicon, titanium nitride | N/A | N/A | DiI, Nissl to verify probe position |
[
|
| Recording | N/A | Hippocampus, cortex | N/A | 5.5 mm × 180 µm (hippocampus), 2 mm × 230 µm wide (cortex) | 30 µm diameter | Below 10 MΩ at 1 kHz | Parylene‐C, platinum, titanium/aluminium | N/A | N/A | N/A |
[
|
Figure 5A) Young's modulus on log scale for brain tissue and neural probe materials, with silicon as the stiffest common substrate. B) The effective bending stiffness values of the most relevant implantable probe styles.
Figure 6Evolutionary trend of the neural probe shape and material from very stiff needle‐like shaft to soft material‐based mesh/neuron‐like structures. A) Stiff shank or needle‐like neural probe, B) neural probe with thick fiber and polymer substrate, C) stretchable probe with serpentine metallic structures, D) ultrathin substrate‐based probe, E) ultra‐thin polymer‐based probe with soft conductive material, and F) mesh‐based probe.
Material properties of the most widely adopted flexible substrate and encapsulation materials including: Young's modulus, target tissue, fabrication approaches, layer thickness, and transparency. Polyimide often boasts excellent biocompatibility, coupled with simple fabrication requirements and the lowest single layer thickness. PDMS has a greatly reduced Young's modulus compared to the other materials
| Material | Young's modulus [GPa] | Target tissue | Fabrication | Layer thickness [µm] | Transparency | Hydrophobicity |
|---|---|---|---|---|---|---|
| Parylene‐C | 2.75[
| Rat motor cortex,[
| Vapor deposition[
| 0.04–83[
| 94.7% optical transmittance[
| Super hydrophobic[
|
| PDMS | 3 × 10−4 − 1 × 10−3[
| Mouse hippocampus,[
| Vacuum plasma system[
| 40[
| Optically clear[
| High[
|
| Polyimide | 2.5[
| Rat cortex,[
| Spin coating and curing[
| 1–5[
| Obviously transparent, transmitted above 370 nm[
| 82°[
|
| BCB | 1.9[
| Rat cortex[
| Spin coating, followed by reactive ion etch or E‐beam[
| 20[
| Transmittance of 70–80% in optical range[
| Yes[
|
| COP | 2.6–3.2[
| Rat somatosensory cortex[
| CO2 laser[
| 13–188[
| 91%[
| 88°[
|
| SU‐8 | 3[
| Mouse somatosensory cortex[
| Spin coating and curing[
| 0.9[
| Optically transparent above 400 nm[
| Hydrophobic[
|
Figure 7Various fabrication methods are explained above: A) wet etching, B) adhesive bonding, C) microcasting, D) thin film deposition, E) sputter deposition, F) blade dicing, G) transfer printing of micro‐LEDs (redrawn from[ ]), H) simple fabrication using thermal lamination of gold on COP (redrawn from[ ]), and I) traditional photolithography with gold deposition on polyimide.
Figure 8A) Syringe injectable mesh electronics. B) Microchannel in flexible probe filled with fluid to provide stiffness. C) Rigid shuttle and miniaturized probe with ribbon cable attached. D) Flexible probe coated in a biocompatible dissolvable material.
Figure 9A) Piezoelectric energy harvester. B) Flexible subdermal solar cell. C) Far‐field electromagnetic coupling. D) Mid‐field electromagnetic coupling. E) Near‐field electromagnetic coupling. F) Triboelectric energy harvester. G) Thermoelectric energy harvester. A–E) Adapted.[ ] F) Adapted.[ ] G) Adapted.[ ]
Characteristics of wireless power transfer and energy harvesting technologies. The most important aspect of such a system involves balancing the size of the implant with its power output
| Power transfer system | Generates | Biocompatibility | Experiment length | Experiment type | Flexibility | Size | Reference |
|---|---|---|---|---|---|---|---|
| Ultrasonic | Harvests maximum of 5 Vpp | Encapsulated with parylene‐C | N/A | In vitro | Flexible PCB | 3.8 mm × 0.84 mm × 0.75 mm |
[
|
| Ultrasonic | 22.25% electromechanical coupling | Encapsulated with PDMS | N/A | Tested in water | Yes | 16 elements measuring 1 mm × 1 mm × 100 µm |
[
|
| Triboelectric, ultrasonic | 2.4 V × 156 µA | N/A | N/A | Ex vivo | Flexible PCB and polymer layers | 4 cm × 4 cm |
[
|
| Electromagnetic | Coupling 500 mW, receives 200 µW in the brain | Far below SAR limit for 500 mW coupling | N/A | In vivo | Rigid patterned metal | 2 mm diameter, 3.5 mm height, weighing 70 mg |
[
|
| Electromagnetic | 19 mW | Planned for future work | N/A | Computer Model, Phantom | No | 0.9 mm3 |
[
|
| Photovoltaic | 90 µW minimum | Planned for future research | 34 min | Ex vivo | Yes | 64 × 37 mm |
[
|
| Photovoltaic | 647 µW | Encapsulated in PDMS | 5 weeks | In vivo | Yes | 760 µm × 760 µm × 5.7 µm, plus encapsulation layers |
[
|
| Photovoltaic | 60 µW | Yes, tested in vitro | 3 days | In vivo | N/A | 390 µm × 410 µm × 1.5 µm |
[
|
| Triboelectric | 4 V | Encapsulated with PVA or PLGA | 9 weeks | In vivo | Yes, polymer‐based | 2 × 3 cm |
[
|
| Thermoelectric | 645 µW | Biocompatible insulator used | 20 min | In vivo | N/A | Surface area 0.83 cm2 |
[
|
| Thermoelectric | 25 mV | Requires encapsulation | >260 s | In vitro, in vivo | No | 10 mm × 10 mm × 3.9 mm |
[
|